RNC Pharma: For the first time in 5 years, the range of foreign drugs in Russia has resumed growth
28 January 2025
For the first time since 2019, the Russian pharmaceutical market has seen an increase in the range of foreign drugs. Data from the Monitoring of the Release of Medicines into Free Circulation in the Russian Federation reveals that approximately 5.99 billion packages were introduced to the pharmaceutical market in 2024, marking a 2% increase compared to 2023’s 5.88 billion packages.
RinLis, a Russian ultra-fast insulin, is now registered
27 January 2025
The Russian Ministry of Health has issued a registration certificate to the Russian pharmaceutical company Geropharm for the drug RinLis® (insulin lispro), which is an ultra-fast insulin based on the active substance insulin lispro.
Sustainability and technology advancement driving spectroscopy market
27 January 2025
Integration of industry 4.0 is anticipated to steer growth of the process spectroscopy market into the next decade, a report predicts.
Antimonopoly Service: Prices for hundreds of drugs dropped by 16% in 2024
24 January 2025
In 2024, the Federal Antimonopoly Service (FAS) successfully lowered the prices of 820 medications across 95 international nonproprietary names (INN). Their cost decreased by an average of 16%, the press service of the agency reported.
Early-phase ATMP clinical trials see promising growth
24 January 2025
Cell and Gene Therapy Catapult’s (CGT Catapult) findings attest to the UK remaining “a highly attractive destination for clinical trials”.
17 new drugs added to the list of vital and essential drugs
23 January 2025
Russian Prime Minister Mikhail Mishustin has signed an order to expand the list of vital and essential drugs (VED) by adding new items. These are 17 names of drugs covering a wide range of diseases.
Sechenov University has opened its Representative Office in Hangzhou (China)
23 January 2025
The opening ceremony took place on January 17. The Representative Office will serve as a hub for promoting Russian medical education, expanding opportunities for academic exchange, and fostering scientific partnerships between the two countries.
A Moscow region manufacturer of blood collection systems is expanding its capacity
22 January 2025
The Moscow Region enterprise Granat Bio Tech, located in the Dubna special economic zone, has significantly increased its production capacity. The regional Ministry of Investment, Industry, and Science has reported that the annual production of vacuum systems designed for collecting biomaterial is projected to reach an impressive 210 million units.
A biotechnology and medicine center has opened in Mordovia
22 January 2025
The Center for the Development of Biotechnology and Medicine opened at Ogarev Mordovia State University on January 16, 2025. It includes a number of unique research laboratories, as well as an educational unit and a university clinic
Long-term potential revealed for novel modifier gene therapy
21 January 2025
The positive two-year findings from the Phase I/II gene therapy trial in retinitis pigmentosa reiterate the potential of mutation-agnostic therapies.
Merry Christmas and Happy New Year!
28 December 2024
NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
Enhancing spectroscopy analysis with machine learning
03 February 2025
The production of new Russian “super antibiotic” to begin in Novosibirsk
03 February 2025
A Russian company has started producing 4 veterinary vaccines
31 January 2025
The government held its first meeting on the “New technologies for preserving health” project
31 January 2025